Biologic quantification, made simple & reliable.
Precision made practical
Supporting faster, more confident decisions with accessible tools.
We develop tools that simplify the measurement of biologics without compromising on data quality or performance. Whether you’re working in research, development, or process optimisation, our platform is designed to deliver reliable results, streamline everyday workflows, and fit seamlessly into your existing lab environment.
Amperia™: Fast, accurate, accessible quantification
Amperia™ is powered by RED (Redox Electrochemical Detection) for direct measurement of biologics.
Built on patented sensor technology and designed for usability, it delivers consistent results through streamlined workflows. Amperia™ supports a wide range of biomolecules, including proteins, viral vectors, tagged constructs, and more, across applications from early research to process development.
Our products.
We develop products that simplify and accelerate the quantification of proteins, viral vectors, and other biomolecules.
Our system includes user-friendly instrumentation, assay kits tailored for different targets, precision sensors, and validated reagents, designed to work together and support reliable, efficient analysis across a wide range of applications.

Platform
Compact systems for efficient quantification workflows.

Assay Kits
Ready-to-use kits for specific applications.
Sensors
Detection components tailored to your assay.

Consumables & Reagents
Validated components for smooth daily use.
Tools for biologics innovation.
We build tools that help teams move faster, with confidence – removing barriers between measurement and decision-making.
Whether you’re developing new cell lines, comparing antibody formats, or advancing gene therapies, our platform supports the practical, day-to-day work of biologics development. It’s designed to fit into real workflows, deliver consistent results, and make complex measurement easier to manage.
Resource library.
Case studies.
What's new.
We’re pleased to share a new interview with Dr Ruizhi Wang, CEO of Abselion, conducted by The Medicine Maker’s editorial team. In this conversation,...
Abselion has received the Best Antibody Discovery Platform 2026 – UK award in the GHP Biotechnology & Lifesciences Awards 2026, recognising the...
Abselion contributes to AZoNetwork’s latest Industry Focus eBook, highlighting practical approaches to protein quantification using the Amperia™...
BioTechniques recently featured an interview with Dale Gordon, who recently joined Abselion as Chair of the Board, exploring what it takes for life...
Abselion Appoints Dale Gordon as Chair Bioprocessing leader to drive continued commercial development and international expansion Cambridge, UK, and...
Abselion Establishes US Subsidiary in Cambridge, MA Supports closer engagement with scientists in North America, to meet growing international...
Find out how Abselion can help accelerate your workflows.









